Benzimidazole derivatives as EP4 antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708311
APP PUB NO 20160214977A1
SERIAL NO

14649896

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel benzimidazole derivatives of the general formula

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER ANIMAL HEALTH GMBHKAISER-WILHELM-ALLEE 20 LEVERKUSEN 51373

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blume, Thorsten Wuppertal, DE 18 123
Bräuer, Nico Falkensee, DE 18 16
Kaulfuss, Stefan Berlin, DE 23 81
Kuhnke, Joachim Potsdam, DE 46 199
Langer, Gernot Falkensee, DE 27 119
Nagel, Jens Daxweiler, DE 52 1914
Peters, Olaf Tabarz, DE 38 156
Ter, Laak Antonius Berlin, DE 34 105
Zorn, Ludwig Berlin, DE 58 394

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00